Search

everythinglearnresearchcommunity

for

Search:↓

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

The study suggests that hypothyroidism may cause alopecia areata.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Targeting NETs may help reduce fibrosis in Crohn's disease.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The summit aimed to speed up finding treatments for alopecia areata.

The Siah1 and Siah2 genes are active in mouse skin development and hair growth, especially right after birth.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.

Finasteride helps female-pattern hair loss.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Low vitamin D levels are linked to severe and active alopecia areata.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Denosumab treatment for osteoporosis can cause hair loss.